KOL Perspectives: IL-6 inhibitors in Rheumatoid Arthritis
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
› The briefing includes analysis of KOL opinion on the following topic areas:
– Current or anticipated future use of sarilumab in RA
– Current use of tocilizumab in RA
– Expected future change to sarilumab & tocilizumab use
– Comparison of sarilumab & tocilizumab clinical profile in RA
– Non-clinical differentiating factors between sarilumab & tocilizumab
– Impact of and factors contributing to sirukumab discontinuation in RA
– IL-6 inhibitors vs. JAK inhibitors in RA
– KOL awareness of olokizumab currently in development for RA
Scope
› The briefing is based on Sociable Pharma’s analysis of primary research with our RA key opinion leaders (KOLs)
› In total, we conducted interviews with 10 KOLs:
– Five Europe-based & five US-based
– Interviews performed in December 2017
> KOL data is analyzed to produce:
– Charts summarizing KOL opinions
– Chart call-outs of key information & details
– KOL quotes
– Summary of KOL reporting trends
– Insight from Sociable Pharma's analysts
Key Highlights
Majority of US but not EU patients have access to sarilumab, with KOLs primarily positioning sarilumab in MTX-IR patients or after anti-TNFs
Most KOLs position tocilizumab after anti-TNFs, partly due to payer pressure, with first-line use possible in MTX-IR or ineligible patients
In the next 12 months, most KOLs expect an increase in use of sarilumab, and a reduction in use of tocilizumab
Reasons to Buy
Combines Qualitative & semi-quantitative insight from key opinion leaders on " IL-6 inhibitors in Rheumatoid Arthritis "
Includes insight & recommendations from our disease-specific healthcare analysts
Utilizes independent expert viewpoints to validate the impact of new clinical data & emerging trends on management of rheumatoid arthritis
Provides cost-effective support for your advisory boards, with topics acting as a catalyst for further expert discussion
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.